Drug name - Avycaz

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7112592 ALLERGAN Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
Jan, 2026

(3 years from now)

US8471025 ALLERGAN Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
Aug, 2031

(8 years from now)

US9284314 ALLERGAN Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
Jun, 2032

(9 years from now)

US9695122 ALLERGAN Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
Jun, 2032

(9 years from now)

US8969566 ALLERGAN Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
Jun, 2032

(9 years from now)

CN104592229A ALLERGAN Polymorphic Form And False Polymorphic Form Of Medicine Composition
Aug, 2019

(3 years ago)

CN1289500C ALLERGAN Nitrogen Heterocyclic Ring Compounds, Their Preparation Method And Their Application As Medicine, Especially Application As Antibacterial Agent
Jul, 2021

(1 year, 2 months ago)

CN1468242A ALLERGAN Nitrogen Heterocyclic Ring Compounds, Their Preparation Method And Their Application As Medicine, Especially Application As Antibacterial Agent
Jul, 2021

(1 year, 2 months ago)

CN102834395B ALLERGAN Polymorphic Form And False Polymorphic Form Of Medicine Composition
Oct, 2030

(8 years from now)

CN102834395A ALLERGAN Polymorphic Form And False Polymorphic Form Of Medicine Composition
Oct, 2030

(8 years from now)

CN105294690A ALLERGAN The Preparation Comprises -7 - Oxo -6-(Sulfo-Oxy) -1, 6-Diazabicyclo [3 2 1] Octane - -2 - Formamide Heterocyclic Compound And Salt Thereof
Jun, 2032

(9 years from now)

CN103649051A ALLERGAN Method For Preparing Heterocyclic Compound Comprising Reverse-7-Oxo- -6-(Sulfo Group) -1, 6-Two [3, 2, 1] -2 -Carboxamide And The Salt Thereof
Jun, 2032

(9 years from now)

CN105294690B ALLERGAN Preparation Comprising Anti - -7 - Oxo - -6-(Sulfo Group) -1, 6-Di-Aza-Bicyclo (3, 2, 1] -2 - Formamide Heterocyclic Compound And Its Salt Method
Jun, 2032

(9 years from now)

CN103649051B ALLERGAN Method For Preparing Heterocyclic Compound Comprising Reverse-7-Oxo- -6-(Sulfo Group) -1, 6-Two [3, 2, 1] -2 -Carboxamide And The Salt Thereof
Jun, 2032

(9 years from now)

IN248632B ALLERGAN Azabicyclic Heterocyclic Compound
Jul, 2021

(1 year, 2 months ago)

IN238630B ALLERGAN Process For The Preparation Of A Heterocyclic Compound
Jul, 2021

(1 year, 2 months ago)

IN200503239P1 ALLERGAN Compound Of General Formula (I) Or One Its Salts With A Base Or An Acid
Jul, 2021

(1 year, 2 months ago)

IN200300268P1 ALLERGAN Azabicyclic Compounds, Preparation Thereof And Use As Medicines, In Particular As Antibacterial Agents
Jul, 2021

(1 year, 2 months ago)

EP1307457B1 ALLERGAN Azabicyclic Compounds, Preparation Thereof And Use As Medicines, In Particular As Antibacterial Agents
Jul, 2021

(1 year, 2 months ago)

EP1307457A1 ALLERGAN Azabicyclic Compounds, Preparation Thereof And Use As Medicines, In Particular As Antibacterial Agents
Jul, 2021

(1 year, 2 months ago)

EP3269717A1 ALLERGAN Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl104
Oct, 2030

(8 years from now)

EP3269717B1 ALLERGAN Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl104
Oct, 2030

(8 years from now)

EP2486038B1 ALLERGAN Polymorphic And Pseudopolymorphic Forms Of A Pharmaceutical Compound
Oct, 2030

(8 years from now)

EP2486038A1 ALLERGAN Polymorphic And Pseudopolymorphic Forms Of A Pharmaceutical Compound
Oct, 2030

(8 years from now)

EP2721005B1 ALLERGAN Process For Preparing Heterocyclic Compounds Including Trans-7-Oxo-6-(Sulphooxy)-1,6-Diazabicyclo[3,2,1]Octane-2-Carboxamide And Salts Thereof
Jun, 2032

(9 years from now)

EP2721005A1 ALLERGAN Process For Preparing Heterocyclic Compounds Including Trans-7-Oxo-6-(Sulphooxy)-1,6-Diazabicyclo[3,2,1]Octane-2-Carboxamide And Salts Thereof
Jun, 2032

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7612087 ALLERGAN Heterocyclic compounds as inhibitors of beta-lactamases Nov, 2026

(4 years from now)

US8835455 ALLERGAN Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt Oct, 2030

(8 years from now)

More Information on Dosage
Strength Dosage Availability
EQ 0.5GM BASE;2GM/VIAL POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.